NCT05519514View on ClinicalTrials.gov

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

August 8, 2021

Study Completion Date

November 15, 2021

Conditions
Healthy SubjectsHuman VolunteersHealthy ParticipantsBioequivalence
Interventions
DRUG

Cortiment

Budesonide 9 mg prolonged release tablets

DRUG

Budesonide

Experimental (Budesonide 9 mg prolonged release tablets)

Trial Locations (1)

Unknown

Study Site, Mangalore

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT05519514 - Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects | Biotech Hunter | Biotech Hunter